Industry Briefs: Mar. 19, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Mar. 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Bend Reasearch has launched a biotherapeutics-development initiative. Read More

OctoPlus has formed an agreement with a top-five generic-drugs company for the development of a formulation for an injectable drug. Read More

QRxPharma has signed a license and option agreement with Actavis. Read More

Recipharm has been contracted by ViroPharma to complete a full commercial scale-up manufacture of DuoCort’s Plenadren (hydrocortisone modified-release tablet). Read More

Shire plans to acquire FerroKin BioSciences for an upfront payment of $100 million. Read More

ThromboGenics has formed a commercialization agreement for Ocriplasmin with Alcon. Read More

People News

Stuart E. Needleman has been named president and chief operating officer of Aptuit, effective immediately. Read More

Avanir Pharmaceuticals has appointed Rohan Palekar as chief commercial officer. Read More

Unigene has appointed David Moskowitz as chief financial officer. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here